Next Article in Journal
Hepatoprotective and Antioxidant Effect of Pisonia aculeata L. against CCl4-Induced Hepatic Damage in Rats
Previous Article in Journal
Ureidopyridazine Derivatives as Acyl-CoA: cholesterol acyltransferase Inhibitors
Article Menu

Article Versions

Export Article

Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence. Articles are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Open AccessArticle
Sci. Pharm. 2008, 76(2), 185-202; https://doi.org/10.3797/scipharm.0803-10 (registering DOI)

Synthesis and Pharmacological Evaluation of New 2-Substituted-5-{2-[(2-halobenzyl)thio)phenyl}-1,3,4-oxadiazoles as Anticonvulsant Agents

1
Department of Medicinal Chemistry, Faculty of Pharmacy, Shahid Beheshti University (M.C), Tehran, Iran
2
Pharmacology, Faculty of Pharmacy, Shahid Beheshti University (M.C), Tehran, Iran
3
Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran
*
Author to whom correspondence should be addressed.
Received: 16 March 2008 / Accepted: 14 April 2008 / Published: 20 April 2008
PDF [374 KB, uploaded 27 December 2016]

Abstract

A new series of 2-substituted-5-{2-[(2-halobenzyl)thio)phenyl}-1,3,4-oxadiazoles was designed, synthesized and investigated for anticonvulsant activities. The designed compounds contain the main essential pharmacophore for binding to the benzodiazepine receptors. Conformational analysis and superimposition of energy minima conformers of designed molecules on estazolam, a known benzodiazepine receptor agonist, revealed that the main characteristics of the proposed benzodiazepine pharmacophore were well matched. Electroshock and pentylenetetrazole-induced lethal convulsion tests showed that some of the synthesized compounds had significant anticonvulsant activity. The structure-activity relationship study of these compounds indicated that the introduction of an amino group at position 2 of 1,3,4-oxadiazole ring and a fluoro substituent at the ortho position of the benzylthio moiety had the best anticonvulsant activity. Anticonvulsant effects of active compounds were antagonized by flumazenil, a benzodiazepine antagonist, which establish the involvement of benzodiazepine receptors in these effects.
Keywords: Benzodiazepine receptor; 1,3,4-Oxadiazoles; Anticonvulsant; SAR Benzodiazepine receptor; 1,3,4-Oxadiazoles; Anticonvulsant; SAR
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

ZARGHI, A.; HAMEDI, S.; TOOTOONI, F.; AMINI, B.; SHARIFI, B.; FAIZI, M.; TABATABAI, S.A.; SHAFIEE, A. Synthesis and Pharmacological Evaluation of New 2-Substituted-5-{2-[(2-halobenzyl)thio)phenyl}-1,3,4-oxadiazoles as Anticonvulsant Agents. Sci. Pharm. 2008, 76, 185-202.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Sci. Pharm. EISSN 2218-0532 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top